Precigen
Price & Volume
Stats
See moreOpen | $1.91 |
Previous Close | $1.91 |
Day Range | $1.80-$1.95 |
52W Range | $0.65-$2.17 |
Market Cap | $569.1M |
Shares Short | 28M |
Financials
See moreRevenue (12 Mos) | $4.2M |
Revenue Growth (YoY) | 25.9% |
Gross Profit (12 Mos) | -$53.1M |
Diluted EPS | -$0.55 |
News
See moreYahoo Finance • yesterday
Inovio Pharmaceuticals’ SWOT analysis: dna immunotherapy firm’s stock faces pivotal year
Yahoo Finance • 2 days ago
JMP analyst reiterates Market Outperform rating on Inovio stock
Yahoo Finance • 2 years ago
Precigen Receives Breakthrough Therapy Designation for PRGN-2012 AdenoVerse™ Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis
Yahoo Finance • 2 years ago
13 High Growth Pharma Stocks that are Profitable
About
CEO | Dr. Helen Sabzevari MPH, Ph.D. |
Address | 20374 Seneca Meadows Parkway, Germantown, MD, United States, 20876 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 143 |
